Simple Summary The main aim of this retrospective study was to investigate the dynamic
evolution and prognostic role of patients affected by DTC and IR after initial therapy. From …

Objective Whether the initiating time of radioiodine (RAI) therapy will affect the clinical
outcome in differentiated thyroid cancer (DTC) remains controversial. The objective of this …

Purpose We investigated whether predictive clinicopathologic factors can be affected by
different response criteria and how the clinical usefulness of radioactive iodine (RAI) therapy …

Introduction Patients with incomplete response to initial therapy of thyroid cancer can be
managed with ongoing observation or potentially additional therapies. Our aim was to …

Background Total thyroidectomy (TT) or lobectomy without radioactive iodine (RAI) is
becoming a common management for patients with low-risk differentiated thyroid cancer …

BacKgrouNd: although differentiated thyroid cancer (dTc) has relatively favorable course,
factors predicting the course of the disease are intensively searched. The aim of the study …

Background There are no definite recommendations on the optimal time of initiating
radioactive iodine (RAI) therapy for differentiated thyroid cancer (DTC) patients in current …

Aim: Based on the response criteria of the 2015 American Thyroid Associations guidelines,
our objectives were to determine the response rate when using a low dose of 131-I GBq in …

Background and Purpose This study aimed to analyze the diagnostic ability of the
combination of stimulated thyroglobulin (sTg) and antithyroglobulin antibody (TgAb) in …

Purpose Although postoperative radioiodine (RAI) therapy has been used in patients with
differentiated thyroid carcinoma (DTC) for many years, there is still lack of data defining the …